New study reveals COVID-19 significantly increases MS relapse rates & shortens time to first relapse but has no short-term effect on EDSS progression. Insights from Yi Chao Foong, Matteo Foschi & team across 12 countries! Read here: journals.sagepub.com/doi/epdf/10.11…

"#COVID-19 infection was associated with a significantly increased [#MultipleSclerosis] #relapse rate and a shorter time to first relapse. There was no difference in confirmed #EDSS progression over a short follow-up period of 1.7 years."

1/2 These publications are a true testament of the hard work & collaborative efforts of so many of our colleagues from Australia & NZ. Dr Jessica Shipley (first author) & I are very grateful! So many clinicians & those with lived experiences of #MS contributed.

Chance for tasmanian RACP members to give feedback on the upcoming 20 year tassie preventative health strategy - racp.edu.au/policy-and-adv… #RACP #politas #Tasmania

Interesting study that shows trough NTZ levels affect JCV seroconversion, with low trough levels reducing risk of seroconversion #multiplesclerosis #MS tinyurl.com/5e9yfh42

No 👎 from Yi Chao Foong University of Tasmania Monash University: Trials and real-world evidence showed that unselected treatment-cessation approach carries an unacceptable risk of disease reactivation. 🔽 journals.sagepub.com/doi/full/10.11… 3/🧵

Thoroughly enjoyed the opportunity to write this controversy in MS article! #MS #multiplesclerosis